A single determination of C-reactive protein does not suffice to declare a patient with a diagnosis of axial spondyloarthritis ‘CRP-negative’

por Landewé, Robert, Nurminen, Tommi, Davies, Owen, Baeten, Dominique
Publicado 2018

Certolizumab pegol treatment in axial spondyloarthritis mitigates fat lesion development: 4-year post-hoc MRI results from a phase 3 study

por Baraliakos, Xenofon, Kruse, Sebastian, Auteri, Simone E, de Peyrecave, Natasha, Nurminen, Tommi , Kumke, Thomas, Hoepken, Bengt, Braun, Jürgen
Publicado 2021

Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcome...

por Braun, Jürgen, Baraliakos, Xenofon, Hermann, Kay-Geert, Landewé, Robert, Machado, Pedro M, Maksymowych, Walter P, Davies, Owen, Hoepken, Bengt, Nurminen, Tommi, Stach, Christian, van der Heijde, Désirée
Publicado 2017

Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III rando...

por van der Heijde, Désirée, Baraliakos, Xenofon, Hermann, Kay-Geert A, Landewé, Robert B M, Machado, Pedro M, Maksymowych, Walter P, Davies, Owen R, de Peyrecave, Natasha, Hoepken, Bengt, Bauer, Lars, Nurminen, Tommi, Braun, Juergen
Publicado 2018